Consequently, we conducted a comprehensive examination of the impact of FDX1 on various aspects of glioblastoma multiforme's (GBM) tumor microenvironment (TME), metabolic pathways, immune micro-environment, and drug responsiveness. Here, FDX1 is linked to glioblastoma.